Ra Medical Systems Inc recalls The DABRA Laser (model RA-308) is designed to provide ultraviolet laser energy endovascularly through a catheter to occ…
- Recall date
- February 15, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2218-2019
- FDA classification
- Class II
- Brand / firm
- Ra Medical Systems Inc
- Sold / distributed
- U.S: CA, PA
Why it was recalled
Lasers/Catheters did not calibrate during set-up prior to use.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
The DABRA Laser (model RA-308) is designed to provide ultraviolet laser energy endovascularly through a catheter to occluded lesions in the peripheral arteries to cross them. The system is a self-contained unit that consists of a light source unit and a single use catheter. The light source contains a microprocessor with software to provide safety features and a user-friendly interface. The laser operates by producing a high current discharge within a chamber that is filled with rare gases and halogen. The discharge produces pulses of UV light, which is amplified by reflecting the energy within the resonating chamber many times. The output is directed to the desired target location by the catheter. A footswitch connected to the light source controls the laser action.
Get recall alerts
Free email alert whenever Ra Medical Systems Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ra Medical Systems Inc